JTCVS Techniques最新文献

英文中文

Multiarm single-port robot-assisted secondary carinal reconstruction for right main bronchial schwannoma: A case report 多臂单口机器人辅助右主支气管神经鞘瘤二次隆突重建1例

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-26 DOI: 10.1016/j.xjtc.2025.102164

Yueying Yang MM , Ao Li BM , Yunfei Gao MM , Kayishaer Ainiwaer BM , Jun Chen MM , Dongbo Luo PhD

引用次数: 0

Temperature performance of a commercially available hybrid power cooler for cardiac allograft preservation 市售混合动力冷却器保存异体心脏移植物的温度性能

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-26 DOI: 10.1016/j.xjtc.2025.102167

Mark Petrovic MS , John M. Trahanas MD , Stephen DeVries DMSc, PA-C , Joshua Lowman PA-C , Chen Chia Wang BSc , Awab Ahmad MD , Brian Lima MD, MBA , Clifton Keck BS , Chris Schwartz BS , Ashish S. Shah MD , Matthew Bacchetta MD, MBA , Swaroop Bommareddi MD , Aaron M. Williams MD

引用次数: 0

Papillary muscle relocation for mitral regurgitation attributable to flail but tethered commissure associated with a left ventricular aneurysm 二尖瓣返流的乳头肌移位可归因于连枷，但联系性联合左心室动脉瘤

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-26 DOI: 10.1016/j.xjtc.2025.102166

Hiromitsu Teratani MD , Kiyoyuki Eishi MD, PhD , Kikuko Obase MD, PhD , Yuko Nakao MD , Kazuki Hisatomi MD, PhD , Takashi Miura MD, PhD

引用次数: 0

Erratum to “Proximalization of the distal anastomosis in frozen elephant trunk surgery”, JTCVS Techniques, Vol. 33, 2025, pp 38-50. “冷冻象鼻手术中远端吻合术的近端化”的勘误，中华医学杂志，Vol. 33, 2025, pp . 38-50。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-25 DOI: 10.1016/j.xjtc.2025.102165

Philipp Pfeiffer MD, Karen Wittemann, Edoardo Zancanaro MD, Vanessa Buchholz, Leon Mattern, Chris Probst MD, Franz Masseli MD, Ahmed Ghazy MD, Hendrik Treede MD, PhD, Daniel-Sebastian Dohle MD, PhD

引用次数: 0

Totally endoscopic extensive resection and reconstruction of the left atrial wall for myxoma with unusual origin 来源不寻常的左房壁黏液瘤的全内镜广泛切除与重建

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-21 DOI: 10.1016/j.xjtc.2025.11.005

Huy Q. Dang PhD, MD , Huong T. Le MD , Phu D. Bui PhD, MD

引用次数: 0

Transcatheter aortic valve replacement infective endocarditis presenting as ascending aorta false aneurysm—a new clinical entity? 经导管主动脉瓣置换术感染性心内膜炎表现为升主动脉假动脉瘤-一个新的临床实体？

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-21 DOI: 10.1016/j.xjtc.2025.10.030

Pablo Codner MD , Victor Rubchevsky MD , Ashraf Hamdan MD , Janan Awesat MD , David Belkin MD , Yaron Shapira MD , Hilla Shaked MD , Hana Bernstine MD , Mordehay Vaturi MD , Ran Kornowski MD , Dror B. Leviner MD , Katia Orvin MD , Ram Sharony MD

Objectives

Infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) is rare. We describe patients referred to a tertiary heart center endocarditis team, with post-TAVR IE complicated by infected ascending aorta false aneurysms.

Methods

Among 60 patients with post-TAVR IE who were referred to our center between January 2016 and October 2024, 7 (11.7%) patients were complicated by false aneurysm and aortitis. In all cases, self-expanding transcatheter heart valves (THVs), primarily Symetis ACURATE neo, were used.

Results

Infected false aneurysm formation mainly at the tip of the THV stabilization arches and aortitis were identified only on cardiac computerized tomography. Five patients underwent surgical explant of the TAVR valve with aortic valve replacement. Interposition graft replacement of the ascending aorta was performed in 4 cases whereas 1 patient underwent aorta patch repair. Mitral valve surgery and coronary artery bypass graph were performed as a concomitant procedure in 2 cases. Two patients were managed conservatively due to extreme surgical risk. One patient died perioperatively, and one patient died during follow-up.

Conclusions

Unlike prosthetic valve endocarditis after surgical aortic valve replacement, TAVR-IE may involve the ascending aorta, leading to life-threatening false aneurysm formation at the tip of the THV stabilization arches, where the device was adherent to the aortic wall. This pathology often eludes detection by echocardiography, underscoring the essential role of cardiac computed tomography in diagnosis and surgical planning. Clinicians should maintain a high index of suspicion for this rare but unique life-threatening complication and consider early use of advanced imaging.

目的经导管主动脉瓣置换术（TAVR）后并发感染性心内膜炎（IE）较为少见。我们描述了三级心脏中心心内膜炎小组的患者，tavr后IE并发感染的升主动脉假动脉瘤。方法2016年1月至2024年10月至本中心收治的60例tavr术后IE患者中，7例（11.7%）合并假性动脉瘤和主动脉炎。所有病例均使用自膨胀经导管心脏瓣膜（thv），主要是Symetis accurate neo。结果感染的假性动脉瘤主要在THV稳定弓的顶端形成，主动脉炎仅在心脏计算机断层扫描上被发现。5例患者行TAVR瓣膜置换术。4例行升主动脉间置置换术，1例行主动脉补片修复术。2例合并二尖瓣手术及冠状动脉搭桥术。2例患者因手术风险大而采取保守治疗。1例患者围手术期死亡，1例患者随访期间死亡。结论手术主动脉瓣置换术后出现假瓣膜心内膜炎，TAVR-IE可能累及升主动脉，导致附着于主动脉壁的THV稳定弓尖端形成危及生命的假动脉瘤。这种病理常常无法通过超声心动图检测到，强调了心脏计算机断层扫描在诊断和手术计划中的重要作用。临床医生应该对这种罕见但独特的危及生命的并发症保持高度的怀疑，并考虑早期使用先进的影像学检查。

{"title":"Transcatheter aortic valve replacement infective endocarditis presenting as ascending aorta false aneurysm—a new clinical entity?","authors":"Pablo Codner MD , Victor Rubchevsky MD , Ashraf Hamdan MD , Janan Awesat MD , David Belkin MD , Yaron Shapira MD , Hilla Shaked MD , Hana Bernstine MD , Mordehay Vaturi MD , Ran Kornowski MD , Dror B. Leviner MD , Katia Orvin MD , Ram Sharony MD","doi":"10.1016/j.xjtc.2025.10.030","DOIUrl":"10.1016/j.xjtc.2025.10.030","url":null,"abstract":"<div><h3>Objectives</h3><div>Infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) is rare. We describe patients referred to a tertiary heart center endocarditis team, with post-TAVR IE complicated by infected ascending aorta false aneurysms.</div></div><div><h3>Methods</h3><div>Among 60 patients with post-TAVR IE who were referred to our center between January 2016 and October 2024, 7 (11.7%) patients were complicated by false aneurysm and aortitis. In all cases, self-expanding transcatheter heart valves (THVs), primarily Symetis ACURATE neo, were used.</div></div><div><h3>Results</h3><div>Infected false aneurysm formation mainly at the tip of the THV stabilization arches and aortitis were identified only on cardiac computerized tomography. Five patients underwent surgical explant of the TAVR valve with aortic valve replacement. Interposition graft replacement of the ascending aorta was performed in 4 cases whereas 1 patient underwent aorta patch repair. Mitral valve surgery and coronary artery bypass graph were performed as a concomitant procedure in 2 cases. Two patients were managed conservatively due to extreme surgical risk. One patient died perioperatively, and one patient died during follow-up.</div></div><div><h3>Conclusions</h3><div>Unlike prosthetic valve endocarditis after surgical aortic valve replacement, TAVR-IE may involve the ascending aorta, leading to life-threatening false aneurysm formation at the tip of the THV stabilization arches, where the device was adherent to the aortic wall. This pathology often eludes detection by echocardiography, underscoring the essential role of cardiac computed tomography in diagnosis and surgical planning. Clinicians should maintain a high index of suspicion for this rare but unique life-threatening complication and consider early use of advanced imaging.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"35 ","pages":"Article 102160"},"PeriodicalIF":1.9,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146071035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Durable ventricular assist device as salvage therapy for recurrent free wall rupture: Expanding the indication of the durable ventricular assist device 持久心室辅助装置作为复发性游离壁破裂的抢救治疗：扩大持久心室辅助装置的适应症

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-21 DOI: 10.1016/j.xjtc.2025.10.029

Min-Yuan Liu MD, Chih-Hsien Wang MD, PhD, Ling-Yi Wei MD, Heng-Wen Chou MD, Hsi-Yu Yu MD, PhD, Yih-Sharng Chen MD, PhD

引用次数: 0

Cryoablation as an adjunct to the excision of primary cardiac tumors 冷冻消融作为原发心脏肿瘤切除的辅助手段

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-19 DOI: 10.1016/j.xjtc.2025.09.039

Matthew R. Schill MD, Ruth Obiarinze MD, Sophia R. Pyeatte MD, Tari-Ann Yates MD, June He MBBS, James R. Edgerton MD, Harold G. Roberts Jr. MD, Tsuyoshi Kaneko MD, Ralph J. Damiano Jr. MD

Objective

Resection of atrial myxomas and valvular papillary fibroelastomas has traditionally involved sharp excision of the tumor accompanied by a small margin of normal tissue when feasible. Cryoablation of the tumor base is a potentially effective adjunct to radical excision alone and may prevent collateral damage and/or the need for reconstruction and late recurrence. This study aimed to evaluate the safety and effectiveness of adjunctive cryoablation with cardiac tumor resection.

Methods

We performed a retrospective analysis of all patients from our institution who underwent resection of first occurrence of a myxoma or papillary fibroelastoma between January 1, 1999, and December 31, 2024. Operative reports were reviewed to determine whether cryoablation was used as an adjunct to resection. Echocardiographic images were reviewed to determine tumor recurrence.

Results

Of the 94 patients included in this study, 50 underwent resection with adjunctive cryoablation around the tumor base and 44 underwent sharp excision alone. Fifty-one patients had a myxoma (54%) and 43 patients had a fibroelastoma (46%). Tumor recurrence was detected in 3 (3%) patients overall. All recurrences were in the sharp excision group (3/44, 7%), compared with none in the cryoablation group (P = .098).

Conclusions

Cryoablation was an effective adjunct that reduced recurrence without increasing complications after benign cardiac tumor resection.

目的：心房黏液瘤和瓣膜性乳头状纤维弹性瘤的传统切除方法是在可行的情况下切除肿瘤并保留少量正常组织。肿瘤底部的冷冻消融是单纯根治性切除的潜在有效辅助手段，可以防止附带损伤和/或需要重建和晚期复发。本研究旨在评价心脏肿瘤切除辅助冷冻消融的安全性和有效性。方法回顾性分析1999年1月1日至2024年12月31日期间本院首次行粘液瘤或乳头状纤维弹性瘤切除术的所有患者。回顾了手术报告，以确定是否使用冷冻消融作为切除的辅助手段。回顾超声心动图图像以确定肿瘤复发。结果本研究纳入的94例患者中，50例患者行肿瘤基底周围的辅助冷冻消融切除，44例患者单独行尖锐切除。51例有黏液瘤（54%），43例有纤维弹性瘤（46%）。肿瘤复发3例（3%）。急刀切除组复发均为3/ 44,7 %，而冷冻消融组无复发（P = 0.098）。结论心脏良性肿瘤切除后，切除可有效减少复发，且不增加并发症。

{"title":"Cryoablation as an adjunct to the excision of primary cardiac tumors","authors":"Matthew R. Schill MD, Ruth Obiarinze MD, Sophia R. Pyeatte MD, Tari-Ann Yates MD, June He MBBS, James R. Edgerton MD, Harold G. Roberts Jr. MD, Tsuyoshi Kaneko MD, Ralph J. Damiano Jr. MD","doi":"10.1016/j.xjtc.2025.09.039","DOIUrl":"10.1016/j.xjtc.2025.09.039","url":null,"abstract":"<div><h3>Objective</h3><div>Resection of atrial myxomas and valvular papillary fibroelastomas has traditionally involved sharp excision of the tumor accompanied by a small margin of normal tissue when feasible. Cryoablation of the tumor base is a potentially effective adjunct to radical excision alone and may prevent collateral damage and/or the need for reconstruction and late recurrence. This study aimed to evaluate the safety and effectiveness of adjunctive cryoablation with cardiac tumor resection.</div></div><div><h3>Methods</h3><div>We performed a retrospective analysis of all patients from our institution who underwent resection of first occurrence of a myxoma or papillary fibroelastoma between January 1, 1999, and December 31, 2024. Operative reports were reviewed to determine whether cryoablation was used as an adjunct to resection. Echocardiographic images were reviewed to determine tumor recurrence.</div></div><div><h3>Results</h3><div>Of the 94 patients included in this study, 50 underwent resection with adjunctive cryoablation around the tumor base and 44 underwent sharp excision alone. Fifty-one patients had a myxoma (54%) and 43 patients had a fibroelastoma (46%). Tumor recurrence was detected in 3 (3%) patients overall. All recurrences were in the sharp excision group (3/44, 7%), compared with none in the cryoablation group (<em>P</em> = .098).</div></div><div><h3>Conclusions</h3><div>Cryoablation was an effective adjunct that reduced recurrence without increasing complications after benign cardiac tumor resection.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"35 ","pages":"Article 102158"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146071074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assistant-independent robotic lung transplantation 辅助独立机器人肺移植

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-19 DOI: 10.1016/j.xjtc.2025.11.001

Ji Hyeon Park MD , Samina Park MD , Jimyung Park MD , Sooah Cho MD , Susie Yoon MD , Taeyoung Yun MD , Bubse Na MD , Kwon Joong Na MD , Hyun Joo Lee MD , In Kyu Park MD , Chang Hyun Kang MD , Young Tae Kim MD

引用次数: 0

Najm transconal unroofing and left anterior descending exteriorization with intraventricular course Najm经鼻开顶术及左前降行外置术伴脑室内行

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

JTCVS Techniques

Pub Date : 2025-11-19 DOI: 10.1016/j.xjtc.2025.11.004

Kaoutar Farahi MD , Praise Chovwen MD , Munir Ahmed MD , John P. Costello MD , Nicholas Szugye MD , Shinya Unai MD , Hani K. Najm MD, MSc

引用次数: 0

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

JTCVS Techniques

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀